MD Anderson to expand proton therapy center with $159 million project
Posição atual:
> This Story

Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment




Rad Oncology Homepage

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

New technique may concentrate radiotherapy dose for minimal tissue damage Utilizes very high energy electrons (VHEEs)

MedAustron delivers first bout of carbon ion therapy on patient Sixth center in the world to offer treatment

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Mayo Clinic Florida campus to get $233 million proton facility The 140,000-square-foot facility will house a two-gantry proton system

MD Anderson Cancer Center plans
to more than double the size of its
proton therapy center

MD Anderson to expand proton therapy center with $159 million project

por John R. Fischer , Staff Reporter
The University of Texas MD Anderson Cancer Center has revealed plans to more than double the size of its proton therapy center.

The $159 million project will expand the building to more than 160,000 square feet, enabling it to take in more patients who require treatment with the advanced form of radiotherapy.

Story Continues Below Advertisement

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

"We are excited to more than double our IMPT capacity in the new center to approximate 100 patient treatments per day, better ensuring timely patient access so that more patients can benefit from this technology," G. Brandon Gunn, associate medical director of the Proton Therapy Center at the University of Texas MD Anderson Cancer Center, told HCB News.

The expansion will include eight radiation therapy systems developed by Hitachi that rotate at 360 degrees around patients to deliver therapy to the exact area that requires treatment, a technique known as intensity-modulated proton therapy.

The center will also install an additional synchrotron, the accelerator used to create proton beams, and rooms with improved, modern designs for better patient experiences.

"One of the four treatment rooms in our current center is IMPT capable and is in very high demand by our patients and physicians. Proton therapy expansion at MD Anderson will greatly increase patient access to IMPT, as all four treatment rooms in the new center will be equipped with this advanced technology, more than doubling our current IMPT capacity," said Gunn. "The new center will feature numerous technical advancements that will further improve proton therapy delivery and precision, such as in-room CT volumetric imaging and tumor motion tracking."

The center experienced a nearly 11 percent increase from 2017 to 2018 in the number of patients who underwent proton therapy. The expansion of the 73,500-square-foot facility is expected to provide more accessibility to patients who would benefit greatly from PT. This includes those with cancer of the head and neck, which currently make up 38 percent of the cases at MD Anderson; prostate, lung, liver, and brain, and a range of pediatric cancers.

The expansion is estimated to be completed by November 2023. Construction will be carried out by Gilbane Building Company.

Rad Oncology Homepage

You Must Be Logged In To Post A Comment